[HTML][HTML] Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach

CK Jung, A Bychkov, K Kakudo - Endocrinology and Metabolism, 2022 - ncbi.nlm.nih.gov
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …

Papillary thyroid cancer prognosis: An evolving field

S Ulisse, E Baldini, A Lauro, D Pironi, D Tripodi, E Lori… - Cancers, 2021 - mdpi.com
Simple Summary Over the last couple of decades, the prognostic stratification systems of
differentiated thyroid cancer (DTC) patients have been revised several times in an attempt to …

Deep learning fast screening approach on cytological whole slides for thyroid cancer diagnosis

YJ Lin, TK Chao, MA Khalil, YC Lee, DZ Hong, JJ Wu… - Cancers, 2021 - mdpi.com
Simple Summary Papillary thyroid carcinoma is the most common type of thyroid cancer and
could be cured if diagnosed and treated early. In clinical practice, the primary method for …

High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid

JS Bae, SH Jung, M Hirokawa, A Bychkov… - Endocrine …, 2021 - Springer
Follicular-patterned tumors of the thyroid in the adult population frequently harbor RAS
mutations or PAX8-PPARG rearrangement, but little is known about molecular profiles in the …

Radioactive iodine therapy does not improve cancer-specific survival in Hürthle cell carcinoma of the thyroid

X Wang, X Zheng, J Zhu, Z Li… - The Journal of Clinical …, 2022 - academic.oup.com
Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …

Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma

M De Martino, S Pellecchia, M Decaussin-Petrucci… - Cell Cycle, 2023 - Taylor & Francis
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and lethal neoplasms in
humans, and just limited progresses have been made to extend patient survival and …

Thyroid cancer detection in a routine clinical setting: performance of ACR TI-RADS, FNAC, and molecular testing in prospective cohort study

T Grimmichova, P Pacesova, M Hill, B Pekova… - Biomedicines, 2022 - mdpi.com
The aim of our study was to address the potential for improvements in thyroid cancer
detection in routine clinical settings using a clinical examination, the American College of …

Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study

Z Ding, X Tao, X Deng, B Guo, J Kang, B Wu… - Journal of Cancer …, 2023 - Springer
Purpose Locally advanced papillary thyroid cancer (LAPTC) has poor prognosis. Large-
scale genomic testing has revealed multiple oncogenic drivers which may be essential for …

Systematic evaluation of the anti-tumor effect of Phellinus linteus polysaccharide in thyroid carcinoma in vitro

K Yu, Z Tan, Y Xin - Molecular Biology Reports, 2022 - Springer
Background Thyroid carcinoma (TC) is the most common malignant tumor of the endocrine
system. Phellinus linteus polysaccharide (PLP) physiologically acts as a suitable anti-tumor …

Differentiating benign from malignant thyroid tumors by kinase activity profiling and dabrafenib BRAF V600E targeting

R Hilhorst, A van den Berg, P Boender, T van Wezel… - Cancers, 2023 - mdpi.com
Simple Summary Recurrent non-medullary thyroid cancer (NMTC) is difficult to treat and
therapy options are limited. Of the available compounds, serine/threonine kinase (STK) …